Data / Form D filings / Rejuvenate Bio Inc
Rejuvenate Bio Inc: Form D filings
Rejuvenate Bio Inc, a biotechnology company in San Diego, CA, filed 2 Form D notices with the SEC between 2021 and 2026. The latest, on June 18, 2026, reports $19.5 million sold of a $27 million offering to 35 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 270 N. El Camino Real SUITE F451, San Diego, CA, 92024
- Phone
- (916) 396-3714
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1859067
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | New notice | $27,049,354 | $19,471,354 | $7,578,000 | 35 | Jun 3, 2026 | sec.gov |
| Apr 27, 2021 | New notice | $15,250,000 | $14,575,000 | $675,000 | 22 | Apr 16, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Oliver | Executive Officer, Director | |
| Noah Davidsohn | Executive Officer, Director | |
| David Zhu | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Rejuvenate Bio Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.